The New York Times reports that the Food and Drug Administration “has decided to allow Juul Labs’ vaping products to stay on the market temporarily, citing ‘scientific issues’ that warrant a review of the agency’s ruling last month to ban the company’s e-cigarettes.” The agency’s decision to “conduct an internal review effectively moves the dispute out of the public eye in appellate court, where Juul had initially received a temporary reprieve, and returns it to the agency’s private administrative process.” But the FDA “cautioned that its latest move, first announced in a tweet on Tuesday night, should not be misconstrued as a decision rescinding the original order.” Meanwhile, Bloomberg reports behind a paywall that JUUL Labs “is working with bankers at Centerview Partners to help raise financing as it faces consumer lawsuits and an attempt by federal regulators to ban its e-cigarettes from the US market, according to people with knowledge of the matter.” JUUL also “is getting litigation and restructuring advice from Kirkland & Ellis and Alvarez & Marsal, said the people, who asked not to be identified because they aren’t authorized to speak.” The company “is weighing options including a potential bankruptcy filing, which could change depending on the outcome of its appeal of the Food and Drug Administration’s ban on Juul’s vaping products and other factors, the people said.”

From the news release of the American Association for Justice.